BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
PDX1
,
Response to oxidative stress
,
Allergy to pollen
,
Adipose tissue
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
chronic myeloid leukaemia
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
GAS2
MAN1A1
CXCR4
TPSAB1
AQP9
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
PUJANA_BRCA1_PCC_NETWORK
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
PUJANA_CHEK2_PCC_NETWORK
CAIRO_HEPATOBLASTOMA_CLASSES_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Down Syndrome-AMKL (DS-AMKL) and non-DS-AMKL gene expression from primary cells and cell lines
Gene expression of CML CD34+ cells during imatinib therapy
Mouse Phenotypes - Myeloid leukemia
Expression profile of CREB knockdown in myeloid leukemia cells
Gene expression profiling of CD34+ subsets in CML and healthy individuals
Explore Curated Studies Results
Literature
Most Relevant Literature
Chronic myeloid leukemia: a type of MPN.
CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases.
Bleeding Diathesis as the Initial Presentation of Chronic Myeloid Leukemia: A Case Series.
Recent progress in the management of pediatric chronic myeloid leukemia.
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in …
De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Resp…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ